Freedomcast

In an interview with CFIF, William Conti, an attorney in Washington, D.C., discusses the first debate between former President Trump and Vice President Harris, the impact of endorsements, the status of the fight for the Senate in 2024, and the Republican bench looking forward to 2028.

Sally Pipes, Founder and President of Pacific Research Institute, discusses the impact of drug price controls under the Inflation Reduction Act (IRA), what it means for research and development of life-saving medicines, and how the IRA's drug pricing provisions will reduce access to new cures and treatments and result in longer wait times for existing medicines.

Ambassador Francis Rooney, former U.S. Congressman (R-FL) and former Ambassador to the Holy See, discusses steps the next U.S. president should take to protect our nation and promote America's interests across the globe, the biggest threats to American foreign policy, and a comparison of the foreign policy records of the Biden-Harris Administration and the Trump Administration.

Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses the recent decision by the U.S. Court of Appeals for the Sixth Circuit to put a hold on the FCC's Title II Net Neutrality rules, and how history has proven that the consequences of Title II Net Neutrality are disastrous and immediate.

Phil Kerpen, President of American Commitment, discusses Vice President Kamala Harris's selection of Minnesota Governor Tim Walz to be her running mate, and what the political landscape may look like following the election as it relates to federal regulatory powers.

Virginia Allen, Senior News Producer and Podcast Host at The Daily Signal, discusses the resignation of Secret Service Director Kimberly Cheatle, vulnerabilities exposed by the assassination attempt of former President Trump, and what the future of American politics may look like.

Jarrett Stepman, Columnist with the Daily Signal, discusses President Biden's replacement as the Democrats' presidential candidate, how the process will work at the convention, and the factors that came into play for President Biden to withdraw from the race.

Ilya Shapiro, Senior Fellow and Director of Constitutional Studies at the Manhattan Institute, discusses some of the seminal cases decided late in the U.S. Supreme Court's term, including the decision that rollbacks the Chevron doctrine and constitutes a massive blow to the power of federal agencies, and how the Court drew the line regarding presidential immunity in another decision.

William J. Conti, an attorney from Washington, DC, discusses what would happen if President Biden stepped aside in the 2024 election, whether there is enough time for a new candidate to make a solid run, how the issue of President Biden's health has fractured the Democratic Party, and whether the 25th Amendment to the U.S. Constitution should come into play.

Lauren Stewart, Senior Federal Legislative Liaison at Americans for Prosperity and Concerned Veterans for America, discusses how President Biden is attempting to rewrite his record on healthcare, how his policies have resulted in limited access and increased costs for Americans, and how a personal option healthcare plan can provide more choices and more solutions.

Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.

Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses the current state of the U.S. economy and recent survey data on how Americans are doing financially under the Biden administration, and brings truth to some false statements being peddled by the media on issues related to the economy.

Francis Rooney, former U.S. Ambassador to the Holy See and former Member of the U.S. House of Representatives, discusses the Russia-Ukraine war, Russian President Putin's goal to restore the Iron Curtain, what the death of the leader of Iran may mean for the ongoing conflict between Israel and Hamas, and the role diplomacy should play in conflict mediation.

Karen Kerrigan, President and CEO of the Small Business and Entrepreneurship Council, discusses the Federal Trade Commission's recent ban on the use of non-compete agreements, the slippery slope of such regulatory overreach, lawsuits challenging the rule, and the recent report issued by the U.S. House Committee on Small Business that highlights the significant costs to small businesses and th...

Phil Kerpen, President and Founder of American Commitment, discusses the Biden administration's electric vehicle mandate, what it may mean for Americans looking to purchase gas powered vehicles in the future, and what EV subsidies have really cost us.

Rachel Greszler, Senior Research Fellow in the Roe Institute at The Heritage Foundation, discusses the grim picture painted in the Social Security Trustees' 2024 Report, the history of the Social Security program, what happens when Social Security runs out of money, and commonsense Social Security reforms.

Tzvi Kahn, Research Fellow and Senior Editor at the Foundation for Defense of Democracies, discusses the increasingly dangerous likelihood of full-blown conflict between Israel and Iran, how the election season may be affecting policy, and why the Biden Administration must take seriously Iran's warnings that it will change nuclear doctrine if its existence is threatened.

Jonathan Butcher, the Will Skillman Senior Research Fellow in Education Policy at The Heritage Foundation, discusses the fallout from college student "encampments," the impact of the protest on college enrollment, contributions and employment opportunities, and what the protests mean for this summer's National Conventions, particularly the DNC in Chicago.

William J. Conti, an Attorney from Washington, DC, discusses some of the U.S. Senate races to watch this year, the impact voter turnout for the presidential race may have on the Congressional races, and what Robert F. Kennedy, Jr.'s presidential run might mean for the other candidates.

Federal Communications Commission (FCC) Commissioner Brendan Carr discusses the FCC's upcoming vote on a rule that will subject the internet to crippling, utility-style regulatory powers under Title II of the Communications Act of 1934, the myths and facts surrounding "net neutrality," and how this massive expansion of government power over the internet is unnecessary at a time when Americans...

Ike Brannon, Economist, President of Capital Policy Analytics and a Senior Fellow at the Jack Kemp Foundation, discusses the proposed acquisition of U.S. Steel by Nippon Steel, why the merger would not undermine national security as some opponents claim, how it will keep jobs in the U.S., and what history should teach us about the impact on government overreach and restraints on foreign investment...

Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses the FCC's plan to reinstate crippling utility-style Title II regulations on the Internet, and how further expansion of government power over the Internet could result in less innovation, censorship, and higher costs for consumers.

Doug Kelly, CEO of American Edge Project ("AEP"), discusses AEP's recently released study, "American Innovation Under Siege: Venture Capital Data Reveals Risks from Rising Global Regulatory Overreach," how heavy-handed regulations negatively impact innovation, jobs and U.S. military readiness, and what recommendations the study offers on how the U.S. can win the innovation race against China.

Dr. Currie Myers, Former Sheriff and Law Enforcement Officer and now Professor at Benedictine College, discusses the inaccurate and misleading crime statistics from President Biden's recent State of the Union Address, the role that crime and the fear of crime will play in the upcoming presidential election, how crime is being underreported in America, and what needs to be done at the state, l...

Sally Pipes, President and CEO at the Pacific Research Institute, discusses how President Biden's drug price controls undermine his Cancer Moonshot initiative, and the ultimate impact price controls will have on patient lives, innovation, and research and development.